PMI should forget wellness and focus on smokers who want to quit
In the summer of 2021, public health experts, policymakers and some UK columnists worked themselves into a frenzy over a takeover battle.
Philip Morris International, the maker of Marlboro cigarettes, triumphed in tit-for-tat bidding against private equity group Carlyle to buy Vectura, a UK-listed maker of inhaled medicines, including treatments for smoking-related illnesses.
This story originally appeared on: Financial Times - Author:Helen Thomas
